Please login to the form below

Not currently logged in
Email:
Password:

Valeant adds member to board of directors

President of ValueAct Capital G. Mason Morfitadded to team
Valeant Mason Morfit

Valeant Pharmaceuticals has added G. Mason Morfit, president of ValueAct Capital to its board of directors, effective immediately.

Morfit also currently serves on the board of directors for Microsoft and was former director of CR Bard, Immucor, Advanced Medical Optics and Solexa prior to his role at ValueAct Capital.

Morfit had originally served on Valeant's board of directors between 2007 and 2014.

Michael Pearson, chairman and CEO of Valeant, said: “I am pleased to welcome Mason back to the Valeant board of directors.

“Although Mason has not officially been a part of the Valeant board for more than a year, I have continued to value his vision and guidance, and I believe his insights will be invaluable during this time.”

26th October 2015

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

marketing satnav
Mapping at launch: it’s time to update the satnav
How mapping familiar basics can provide a new GPS for market access strategy that drives brand success...
What does the future hold for Medical Affairs?
Lori Lush, Head of Fishawack Medical, reveals why she’s driven to tell impactful scientific stories, the benefits of cross-functional collaboration, and the trends she predicts for the next five years....
EU health fund
An EU emergency health fund to limit the impact of future crises
Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...

Infographics